TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code
TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code
TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code
TRAD CHI MED: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024
TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code
TRAD CHI MED: List of Directors and their Role and Function
TRAD CHI MED: CHANGE OF DIRECTORS AND PRESIDENT
TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code
TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code
TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code
TRAD CHI MED: Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
TRAD CHI MED: Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
TRAD CHI MED: Interim Report 2024
TRAD CHI MED: JOINT ANNOUNCEMENTMONTHLY UPDATEIN RELATION TO(1) PRE-CONDITIONAL PROPOSAL TO PRIVATISECHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITEDBY THE OFFERORBY WAY OF A SCHEME OF ARRANGEMENTUNDER SECTION 673 OF THE COMPANIES ORDINANCEAND(2) PROPOSED WITHDRA
TRAD CHI MED: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024
TRAD CHI MED: VOLUNTARY ANNOUNCEMENTTHE CATEGORY 3.1 TRADITIONAL CHINESE MEDICINE COMPOUNDPREPARATIONS REGULATED AS THE ANCIENT CLASSIC FORMULAEDANGGUI BUXUE TANG GRANULES APPROVED FOR MARKETING
TRAD CHI MED: ANNOUNCEMENT OF INTERIM RESULTSFOR THE SIX MONTHS ENDED 30 JUNE 2024
TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code
TRAD CHI MED: APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER
TRAD CHI MED: INSIDE INFORMATIONPROFIT WARNING
No Data
No Data